The novel therapy of the medication represents a major advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment